Clinically, different approaches are adopted worldwide for the treatment of cancer, which still
ranks second among all causes of death. Immunotherapy for cancer treatment has been the …

Triple negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC) are amongst
the most aggressive forms of solid tumors. TNBC is highlighted by absence of genetic …

Non-small cell lung cancer (NSCLC) represents the most common and fatal type of primary
lung malignancies. NSCLC is often diagnosed at later stages and requires systemic …

Lung cancer is managed using conventional therapies, including chemotherapy, radiation
therapy, or a combination of both. Each of these therapies has its own limitations, such as …

Even though there are various types of cancer, this pathology as a whole is considered the
principal cause of death worldwide. Lung cancer is known as a heterogeneous condition …

Lung cancer is the most common type of cancer, with over 2.1 million cases diagnosed
annually worldwide. It has a high incidence and mortality rate, leading to extensive research …

RNA-binding proteins (RBPs) modulate the expression level of several target RNAs (such as
mRNAs) post-transcriptionally through interactions with unique binding sites in the 3 …

Lung cancer (LC) is often diagnosed at an advanced stage and conventional treatments for
disease management have limitations associated with them. Novel therapeutic targets are …

Nowadays, the landscape of cancer treatments has broadened thanks to the clinical
application of immunotherapeutics. After decades of failures, cancer immunotherapy …

Lung cancer is one of the common malignant cancers worldwide. Immune checkpoint
inhibitor (ICI) therapy has improved survival of lung cancer patients. However, ICI therapy …